(S)-2-((tert-Butoxycarbonyl)amino)-3-((tert-butyldiphenylsilyl)oxy)propanoic acid, 96.0%, 250mg

(R)-3-Fluoropyrrolidine, 95.0%, 250mg

(1,3-Dioxolan-2-yl)methanol, 95.0%, 25g

Monohidrato de clorhidrato de L-cisteína, mínimo 98,5 %, para bioquímica, 50 g, envase de plástico.

4-(Bromomethyl)-2,2,6,6-tetramethyloxane, 98%, 250mg

morpholine-4-carbonitrile, 99%, 5g

4-Methoxy-N-(4H-1,2,4-triazol-4-yl)benzamide, 90.0%, 100mg

4-Pentyl-pyridin-2-ylamine, 250mg

cis-3-(Aminomethyl)-1-methyl-cyclobutanol hydrochloride, 98%, 250mg

2,3-DICHLORO-6-NITROANILINE, 97.0%, 100mg

2-Methyltetrahydrofuran (stabilized with BHT)>98.0%(GC)500mL

(1s,4s)-4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)cyclohexanecarboxylic acid, 99.0%, 250mg

(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)-4-methoxytetrahydrofuran-3-ol, 98%, 250mg